Afuco™ Anti-Human EPHA10 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-EPHA10 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies specifically bind to the Ephrin type-A receptor 10 with high affinity, used for treating various cancers, including bladder cancer, breast cancer, colorectal cancer, head and neck cancer, kidney cancer, lung cancer, uterine cancer and pancreatic cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-224CL |
| Pricing | Inquiry |
| Host | Human |
| Target | EPHA10 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |